Rumenka Petkovska
Research Subjects
Rumenka Petkovska has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
A. Dimitrovska
Department of Chemistry, Faculty of Pharmacy , “Ss.Cyril and Methodiys” University , Skopje, R. Macedonia
2 shared publications- Claus Cornett
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, Copenhagen 2100, Denmark
2 shared publications Aneta Dimitrovska
1 shared publication
Latest Publications
- 8 July 2008
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (14) , 2159-2173
Chemometrical Approach in Lansoprazole and Its Related Compounds Analysis by Rapid Resolution RP-HPLC Method
Lansoprazole has been determined in the presence of its five related compounds by the Rapid Resolution RP-HPLC method, using Zorbax Eclipse XDB C18 4.6 mm × 50 mm, 1.8 µm particle size column at 25°C and acetonitrile-1% TEA (41.0:59.0 v/v) at pH 6.6 as mobile phase. The total time for chromatographic separation was approximately 3 min. Experimental design was used for experimental screening (Full factorial 23 design) and optimization (Response surface methodology). The quality of separation is measured by resolution (Rs) and a Chromatographic Response Function. The method was validated for its selectivity, linearity, precision, and accuracy.
- 8 July 2008
- Published by Taylor & Francis in Journal of Liquid Chromatography & Related Technologies
- Vol. 31 (14) , 2159-2173
Chemometrical Approach in Lansoprazole and Its Related Compounds Analysis by Rapid Resolution RP-HPLC Method
Lansoprazole has been determined in the presence of its five related compounds by the Rapid Resolution RP-HPLC method, using Zorbax Eclipse XDB C18 4.6 mm × 50 mm, 1.8 µm particle size column at 25°C and acetonitrile-1% TEA (41.0:59.0 v/v) at pH 6.6 as mobile phase. The total time for chromatographic separation was approximately 3 min. Experimental design was used for experimental screening (Full factorial 23 design) and optimization (Response surface methodology). The quality of separation is measured by resolution (Rs) and a Chromatographic Response Function. The method was validated for its selectivity, linearity, precision, and accuracy.
- 5 May 2008
- Published by Taylor & Francis in Analytical Letters
- Vol. 41 (6) , 992-1009
Development and Validation of Rapid Resolution RP-HPLC Method for Simultaneous Determination of Atorvastatin and Related Compounds by Use of Chemometrics
A Rapid Resolution Reversed Phase High-Performance Liquid Chromatography (RR RP-HPLC) method has been developed and validated for the simultaneous determination of atorvastatin and seven related compounds specified as impurities. Experimental design was used during method optimization (full factorial 32 design) and robustness testing (central composite design). Chromatography was performed with mobile phase containing phosphate buffer pH 3.5 and a mixture of 10% (v/v) tetrahydrofuran in acetonitrile as organic modifier. A Zorbax Eclipse XDB C18 Rapid Resolution HT 4.6 mm × 50 mm, 1.8 µm particle size column was used. The developed method allowed determination of Atorvastatin Calcium (ATV Ca) purity and level of impurities in drug substances.
- 5 May 2008
- Published by Taylor & Francis in Analytical Letters
- Vol. 41 (6) , 992-1009
Development and Validation of Rapid Resolution RP-HPLC Method for Simultaneous Determination of Atorvastatin and Related Compounds by Use of Chemometrics
A Rapid Resolution Reversed Phase High-Performance Liquid Chromatography (RR RP-HPLC) method has been developed and validated for the simultaneous determination of atorvastatin and seven related compounds specified as impurities. Experimental design was used during method optimization (full factorial 32 design) and robustness testing (central composite design). Chromatography was performed with mobile phase containing phosphate buffer pH 3.5 and a mixture of 10% (v/v) tetrahydrofuran in acetonitrile as organic modifier. A Zorbax Eclipse XDB C18 Rapid Resolution HT 4.6 mm × 50 mm, 1.8 µm particle size column was used. The developed method allowed determination of Atorvastatin Calcium (ATV Ca) purity and level of impurities in drug substances.
- Open Access
- 1 January 2008
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 58 (3) , 243-256
Use of chemometrics for development and validation of an RP-HPLC method for simultaneous determination of haloperidol and related compounds
A rapid resolution reversed-phase high performance liquid chromatographic (RR RP-HPLC) method has been developed and validated for simultaneous determination of haloperidol and six related compounds. Investigated matrix was a laboratory mixture of a therapeutic active substance haloperidol and its six related compounds in concentration ratio 300:1. Experimental design was used during method optimization (full factorial 23 design) and robustness testing (Central Composite Circumscribed design). Three factors: organic phase variation during gradient elution, flow rate and gradient rise time were independent variables. To estimate the system response during the optimization procedure and robustness testing, resolution (Rs) and a chromatographic response function (CRF) were used. Chromatography was performed with the mobile phase containing phosphate buffer pH 6.5 and acetonitrile as organic modifier. Separation was achieved using gradient elution (organic phase fraction changed linearly from 20 to 72 %) over 7 min. A Zorbax Eclipse XDB C18 Rapid Resolution HT 4.6 mm x 50 mm, 1.8 mum particle size, column was used at 25 degrees C at a flow rate of 1.5 mL min-1. UV detection was performed at 230 nm. The total time for chromatographic separation was 5.5 min with a total analysis time of 7.0 min. The method was validated for its linearity, precision, modal recovery and robustness.
- 1 January 2008
- Published by Walter de Gruyter GmbH in Acta Pharmaceutica
- Vol. 58 (3) , 243-256
Open AccessUse of chemometrics for development and validation of an RP-HPLC method for simultaneous determination of haloperidol and related compounds
A rapid resolution reversed-phase high performance liquid chromatographic (RR RP-HPLC) method has been developed and validated for simultaneous determination of haloperidol and six related compounds. Investigated matrix was a laboratory mixture of a therapeutic active substance haloperidol and its six related compounds in concentration ratio 300:1. Experimental design was used during method optimization (full factorial 23 design) and robustness testing (Central Composite Circumscribed design). Three factors: organic phase variation during gradient elution, flow rate and gradient rise time were independent variables. To estimate the system response during the optimization procedure and robustness testing, resolution (Rs) and a chromatographic response function (CRF) were used. Chromatography was performed with the mobile phase containing phosphate buffer pH 6.5 and acetonitrile as organic modifier. Separation was achieved using gradient elution (organic phase fraction changed linearly from 20 to 72 %) over 7 min. A Zorbax Eclipse XDB C18 Rapid Resolution HT 4.6 mm x 50 mm, 1.8 mum particle size, column was used at 25 degrees C at a flow rate of 1.5 mL min-1. UV detection was performed at 230 nm. The total time for chromatographic separation was 5.5 min with a total analysis time of 7.0 min. The method was validated for its linearity, precision, modal recovery and robustness.